Australia Contraceptive Devices Market Report 2022 to 2030

Australia Contraceptive Devices Market Analysis

$ 3999

Australia's Contraceptive Devices Market is expected to witness growth from $155 Mn in 2022 to $320 Mn in 2030 with a CAGR of 9.50% for the forecasted year 2022-30. Australian women are becoming more aware of the value of family planning and contraception. As a result, there is now a higher need for contraceptive methods. The market is segmented by type and by gender. Some key players in this market include Ansell, Lifestyles Healthcare, Mylan Laboratories, Mankind Pharma, CooperSurgical, Pfizer, Pregna International, and Teva Pharmaceutical.

ID: IN10AUMD005 CATEGORY: Medical Devices GEOGRAPHY: Australia AUTHOR: Jigyasu Bhandari

Buy Now

Australia Contraceptive Devices Healthcare Market Executive Analysis

Australia's Contraceptive Devices Market size is at around $155 Mn in 2022 and is projected to reach $320 Mn in 2030, exhibiting a CAGR of 9.50% during the forecast period. The estimated overall health expenditures for Australia in 2022–2023 are $105.8 billion, or 16.8% of all Australian government spending. 10%, or around 105 billion dollars in the fiscal year 2022, of Australia's economy, will be accounted for by the health industry.

Australian individuals and couples who want to avoid getting pregnant have access to a variety of benefits from contraceptive equipment. When used appropriately and regularly, contraceptive devices are quite successful at preventing pregnancy. They provide a variety of alternatives for preventing pregnancy and can be used by single people or couples, including hormonal and non-hormonal techniques. The majority of contraceptive methods do not involve complicated procedures or surgery and are generally simple to use. Numerous tools can be utilised without the assistance of a healthcare professional at home. There are various options available for people who prefer non-hormonal approaches, including condoms, diaphragms, and copper IUDs.

Australia Contraceptive Devices Market Analysis

Market Dynamics

Market Growth Drivers

Australian women are becoming more aware of the value of family planning and contraception. As a result, there is now a higher need for contraceptive methods. The market for contraceptive devices is experiencing tremendous technological developments that are improving the effectiveness, safety, and use of the devices. The desire for newer and better technologies is being driven by this, and firms that can produce these products are likely to profit. People are delaying having children or opting to have fewer children as lifestyles change. People trying to plan their families, and this is fuelling the market for contraceptive devices. The demand for contraceptive devices is rising as Australia's population rises. The demand for contraceptive devices rises in direct proportion to the number of persons who need contraception.

Market Restraints

In Australia, healthcare providers are primarily responsible for dispensing contraceptive devices, which may restrict some customers' access. Manufacturers may find it difficult to reach a larger market as a result. Even if family planning and contraception are becoming more widely known, there is still a societal stigma associated with using contraceptive methods, especially among some groups of people. This may restrict the market for these products and make it difficult for the makers to generate sizable sales volumes. Australia's regulatory landscape can be difficult for manufacturers to understand and navigate. New contraceptive device innovation may be hampered by the time-consuming and expensive process of obtaining regulatory approval.

Competitive Landscape

Key Players

Ansell (AU)
Lifestyles Healthcare (AU)
Mylan Laboratories
Church & Dwight
CooperSurgical
Pfizer
Pregna International
Teva Pharmaceutical

Recent Notable Deals

August 2022: Aspen Pharmacare, a South African pharmaceutical company, revealed in August 2022 that it had paid AUD 305 million to acquire Bayer's Australian contraception division. The purchase includes the Bayer contraceptive brands Jadelle and Mirena.

Healthcare Policies and Regulatory Landscape

The Therapeutic Goods Administration (TGA), which is in charge of regulating the quality, safety, and efficacy of medical equipment, including contraceptive devices, is in charge of overseeing the regulatory environment for contraceptive devices in Australia. Before they can be used in Australia, all contraceptive devices must pass a stringent assessment process mandated by the TGA. The Australian market for contraceptive devices is impacted by a number of healthcare policies in addition to regulatory constraints. The Pharmaceutical Benefits Scheme (PBS), which offers subsidised access to prescription medicines, including some contraceptive products, is one of the important initiatives. For many Australians, this increases access to and affordability of contraceptive methods.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Contraceptive Devices Market Segmentation

By Type (Revenue, USD Billion):

A condom is a sheath-shaped barrier device used during sexual intercourse to reduce the probability of pregnancy or a sexually transmitted infection (STI). There are both male and female condoms. With proper use, women whose partners use male condoms experience a 2% per-year pregnancy rate. Their use greatly decreases the risk of gonorrhea, chlamydia, trichomoniasis, hepatitis B, and HIV/AIDS, per the World Health Organization Updates in November 2020. To a lesser extent, they also protect against genital herpes, human papillomavirus (HPV), and syphilis. Hence, the other reasons that aid the growth of the contraception devices market are the rising occurrence of STDs and the substantial increase in the population

Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
Intra Uterine Devices (IUD)
Other Devices

By Gender (Revenue, USD Billion):

Based on Gender the contraceptive devices market is segmented into male and female.

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.